These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26350322)

  • 41. [Urinary tract infections, immunity, and vaccination].
    Luna-Pineda VM; Ochoa S; Cruz-Córdova A; Cázares-Domínguez V; Vélez-González F; Hernández-Castro R; Xicohtencatl-Cortes J
    Bol Med Hosp Infant Mex; 2018; 75(2):67-78. PubMed ID: 29658949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary tract infection in children. Part II: Role of host defence and microbial factors.
    Ellison MJ; Jewkes F; Ansari BM
    J Infect; 1995 Jan; 30(1):7-8. PubMed ID: 7751672
    [No Abstract]   [Full Text] [Related]  

  • 43. Metabolism and Fitness of Urinary Tract Pathogens.
    Alteri CJ; Mobley HLT
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody-secreting cells in acute urinary tract infection as indicators of local immune response.
    Kantele A; Papunen R; Virtanen E; Möttönen T; Räsänen L; Ala-Kaila K; Mäkelä PH; Arvilommi H
    J Infect Dis; 1994 May; 169(5):1023-8. PubMed ID: 8169386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New directions in the diagnosis and therapy of urinary tract infections.
    Powers RD
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1387-9. PubMed ID: 2031519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Physiologic factor in intractable bacterial infections].
    Matsumoto T; Takahashi K
    Nihon Rinsho; 1994 Feb; 52(2):315-21. PubMed ID: 8126879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current concepts of molecular defence mechanisms operative during urinary tract infection.
    Weichhart T; Haidinger M; Hörl WH; Säemann MD
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reaching the End of the Line: Urinary Tract Infections.
    Tamadonfar KO; Omattage NS; Spaulding CN; Hultgren SJ
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.
    Chen SL; Wu M; Henderson JP; Hooton TM; Hibbing ME; Hultgren SJ; Gordon JI
    Sci Transl Med; 2013 May; 5(184):184ra60. PubMed ID: 23658245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-8 and the neutrophil response to mucosal gram-negative infection.
    Agace WW; Hedges SR; Ceska M; Svanborg C
    J Clin Invest; 1993 Aug; 92(2):780-5. PubMed ID: 8349817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection.
    Neugent ML; Hulyalkar NV; Nguyen VH; Zimmern PE; De Nisco NJ
    mBio; 2020 Apr; 11(2):. PubMed ID: 32345639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cohort study of bacterial species causing urinary tract infection and urinary tract abnormalities in children.
    Honkinen O; Lehtonen OP; Ruuskanen O; Huovinen P; Mertsola J
    BMJ; 1999 Mar; 318(7186):770-1. PubMed ID: 10082700
    [No Abstract]   [Full Text] [Related]  

  • 53. Urinary tract infection: an overview.
    Barnett BJ; Stephens DS
    Am J Med Sci; 1997 Oct; 314(4):245-9. PubMed ID: 9332263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrent urinary tract infections in women: diagnosis and management.
    Kodner CM; Thomas Gupton EK
    Am Fam Physician; 2010 Sep; 82(6):638-43. PubMed ID: 20842992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of urinary tract infection].
    Graninger W; Presterl E; Radosztics S; Thalhammer F; Emminger W
    Wien Med Wochenschr; 1991; 141(23-24):544-51. PubMed ID: 1810094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unconventional bacteria in urinary tract disease: Gardnerella vaginalis.
    Fairley KF; Birch DF
    Kidney Int; 1983 Jun; 23(6):862-5. PubMed ID: 6604191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Virulence factors of uropathogens].
    Dobrindt U
    Urologe A; 2010 May; 49(5):598-605. PubMed ID: 20411372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary catheter-associated microbiota change in accordance with treatment and infection status.
    Bossa L; Kline K; McDougald D; Lee BB; Rice SA
    PLoS One; 2017; 12(6):e0177633. PubMed ID: 28628622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The natural history of urinary infection in adults.
    Ronald AR; Pattullo AL
    Med Clin North Am; 1991 Mar; 75(2):299-312. PubMed ID: 1996035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.